Facebook Twitter YouTube SoundCloud RSS

REVEALED: Pressure Placed on Pharmacies NOT to Prescribe Hydroxychloroquine for COVID-19

Yesterday, it was announced that the UK government will spend £20 million to purchase stocks of hydroxychloroquine, a known generic antimalarial drug which received considerable attention after Donald Trump began promoting it as a potential cure for COVID-19 back in March.

This is both a partisan political issue as well as a corporate power one. With the 2020 Election beckoning, any thing or person favored or opposed by President Trump will immediately attract the opposite reaction from the media and his political opposition. Additionally, because chloroquine is generic and thus incredibly cheap (only $13 per prescription), it is simply not profitable for the major pharmaceutical companies who naturally want to make as much money as they can during the COVID crisis. Instead, industry representatives are pushing more expensive solutions like Remdesivir made by Gilead pharmaceuticals (roughly $900 per course). It’s no secret how enmeshed Big Pharma is with Washington, it’s political leaders and its health officials like Dr Anthony Fauci who heads the National Institute of Allergy and Infectious Diseases.

As a result of both Democratic Party and mainstream media disdain for Trump, combined with pressure from Big Pharma, it now appears that serious political and financial pressure has been put to bear on pharmacy and drug store outlets across America to discourage doctors from prescribing hydroxychloroquine to patients who are suffering from symptoms of COVID-19. 

One doctor from Dallas has been speaking out – Dr. Ivette C. Lozano spoke to TV news host Laura Ingraham (original aired May 14, 2020). Watch: 

READ MORE COVID-19 NEWS AT: 21st Century Wire COVID-19 Files




Get Your Copy of New Dawn Magazine #203 - Mar-Apr Issue
Get Your Copy of New Dawn Magazine #203 - Mar-Apr Issue